BIOMAT Database Logo BIOMAT Database Logo

Antitumor effect of allogeneic lymphocytes sensitized with tumor-specific immune RNA on human cancer cells. 1979

M Fukushima, and S Machida, and T Nishikawa, and Y Ishikawa

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008263 Macrophage Migration-Inhibitory Factors Proteins released by sensitized LYMPHOCYTES and possibly other cells that inhibit the migration of MACROPHAGES away from the release site. The structure and chemical properties may vary with the species and type of releasing cell. Macrophage Migration Inhibitory Factor,Migration Inhibition Factors, Macrophage,Macrophage Migration Inhibition Factors,Migration Inhibition Factor, Macrophage,Macrophage Migration Inhibitory Factors,Migration-Inhibitory Factors, Macrophage
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012334 RNA, Neoplasm RNA present in neoplastic tissue. Neoplasm RNA

Related Publications

M Fukushima, and S Machida, and T Nishikawa, and Y Ishikawa
[Immunotherapy of postoperative cancer patients with immune RNA-sensitized lymphocytes and tumor antigen].
March 1983, Nihon Geka Gakkai zasshi,
M Fukushima, and S Machida, and T Nishikawa, and Y Ishikawa
[Treatment of malignant glioma by immunotherapy using lymphocytes sensitized with tumor-specific immune RNA (author's transl)].
April 1979, Neurologia medico-chirurgica,
M Fukushima, and S Machida, and T Nishikawa, and Y Ishikawa
[Adoptive immunotherapy of advanced cancer patients with immune RNA-sensitized lymphocytes].
September 1989, Nihon Geka Gakkai zasshi,
M Fukushima, and S Machida, and T Nishikawa, and Y Ishikawa
Adoptive immunotherapy using autologous lymphocytes sensitized with HLA class I-matched allogeneic tumor cells.
July 2006, Oncology reports,
M Fukushima, and S Machida, and T Nishikawa, and Y Ishikawa
Effect of morphine on cell-mediated immune responses of human lymphocytes against allogeneic malignant cells.
June 2005, Journal of experimental & clinical cancer research : CR,
M Fukushima, and S Machida, and T Nishikawa, and Y Ishikawa
Induction of T lymphocytes specific to human gastric cancer using HLA-A matched allogeneic gastric tumor cells.
January 2003, Journal of immunotherapy (Hagerstown, Md. : 1997),
M Fukushima, and S Machida, and T Nishikawa, and Y Ishikawa
Effect of xenogeneic immune RNA on normal human lymphocytes against human osteosarcoma cells in vitro.
March 1977, Journal of the National Cancer Institute,
M Fukushima, and S Machida, and T Nishikawa, and Y Ishikawa
Allogeneic tumor-specific cytotoxic T lymphocytes.
January 1992, Cancer immunology, immunotherapy : CII,
M Fukushima, and S Machida, and T Nishikawa, and Y Ishikawa
Acceleration of allogeneic antitumor immunity with immune RNA in vitro and T-cell suppression by L1210 tumor bearer spleen cells.
February 1981, Cancer research,
M Fukushima, and S Machida, and T Nishikawa, and Y Ishikawa
Tumor-specific allogeneic cells for cancer therapy.
December 2011, Expert opinion on biological therapy,
Copied contents to your clipboard!